109 related articles for article (PubMed ID: 7532018)
1. CD5-positive and CD5-negative plaque-forming cells against poly-L-lysine-treated sheep erythrocytes in patients with systemic lupus erythematosus.
Jones BM; Lau CS; Wong RW
Autoimmunity; 1994; 18(3):189-94. PubMed ID: 7532018
[TBL] [Abstract][Full Text] [Related]
2. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
Suzuki N; Sakane T; Engleman EG
J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
[TBL] [Abstract][Full Text] [Related]
3. Cellular control of antinuclear antibody production. Anti-dsDNA and anti-Sm plaque forming cells in SLE patients and normal individuals.
Weill BJ; Heavey AC; Evans J; Schur PH
Clin Exp Rheumatol; 1985; 3(1):39-47. PubMed ID: 3884204
[TBL] [Abstract][Full Text] [Related]
4. Use of nuclear antigen-coated red cells in hemolytic plaque assays.
Weill BJ; Heavey AC; Kelley VE; Schur PH
J Immunol Methods; 1983 Feb; 57(1-3):327-40. PubMed ID: 6338124
[TBL] [Abstract][Full Text] [Related]
5. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients.
Casali P; Burastero SE; Balow JE; Notkins AL
J Immunol; 1989 Dec; 143(11):3476-83. PubMed ID: 2479680
[TBL] [Abstract][Full Text] [Related]
6. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
Kanda N; Watanabe S
J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
[TBL] [Abstract][Full Text] [Related]
8. The reactivity of sera from patients with systemic lupus erythematosus to seven different species of single and double stranded deoxyribonucleic acids.
Yu CL; Huang MH; Tsai CY; Sun KH; Hsieh SC; Tsai YY; Tsai ST; Yu HS; Han SH
Clin Exp Rheumatol; 1996; 14(2):137-44. PubMed ID: 8737719
[TBL] [Abstract][Full Text] [Related]
9. Effect of age on the expressed B cell repertoire: role of B cell subsets.
Hu A; Ehleiter D; Ben-Yehuda A; Schwab R; Russo C; Szabo P; Weksler ME
Int Immunol; 1993 Sep; 5(9):1035-9. PubMed ID: 7694639
[TBL] [Abstract][Full Text] [Related]
10. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.
Tyrrell-Price J; Lydyard PM; Isenberg DA
Clin Exp Immunol; 2001 Apr; 124(1):118-25. PubMed ID: 11359450
[TBL] [Abstract][Full Text] [Related]
11. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
[TBL] [Abstract][Full Text] [Related]
12. A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies.
Fish F; Ziff M
Arthritis Rheum; 1981 Mar; 24(3):534-43. PubMed ID: 6971103
[TBL] [Abstract][Full Text] [Related]
13. CD5+ B-lymphocytes are as dependent on T-helper cells and as responsive to T-suppressor cells in pokeweed mitogen-stimulated activation as conventional CD5- B-lymphocytes.
Jones BM
Scand J Immunol; 1991 Apr; 33(4):387-92. PubMed ID: 1708165
[TBL] [Abstract][Full Text] [Related]
14. Immune hemolytic assay for identification of human anti-dsDNA antibodies with DNA-coated red blood cells as target cells.
Loftager MK; Koch C; Hellung-Larsen P; Andersen V
APMIS; 1988 Mar; 96(3):194-8. PubMed ID: 2831917
[TBL] [Abstract][Full Text] [Related]
15. Selective detection of autoimmune antibodies to single- and double-stranded DNA by enzyme immunoassay.
Makowski GS; Ramsby ML
Ann Clin Lab Sci; 2003; 33(2):142-8. PubMed ID: 12817617
[TBL] [Abstract][Full Text] [Related]
16. Relationship between complement-fixing (hemolytic) antibodies to single-stranded and double-stranded DNA and the prognosis in systemic lupus erythematosus.
Sasaki T; Kadono T; Endo F; Sekiguchi Y; Saito T; Arakawa M; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1982 Dec; 138(4):341-55. PubMed ID: 6984545
[TBL] [Abstract][Full Text] [Related]
17. Effect of 12 neutralizing anti-cytokine antibodies on in vitro activation of B-cells. Interleukin-12 is required by B1a but not B2 cells.
Jones BM
Scand J Immunol; 1996 Jan; 43(1):64-72. PubMed ID: 8560198
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
19. Specificity of naturally occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus: determination by an enzyme linked immunosorbent assay.
Tauchi M; Kanai Y; Hashimoto H; Hirose S
Immunol Lett; 1986 Jun; 12(5-6):251-6. PubMed ID: 3733157
[TBL] [Abstract][Full Text] [Related]
20. Increased multiclonal antibody-forming cell activity in the peripheral blood of patients with SLE.
Becker TM; Lizzio EF; Merchant B; Reeves JP; Steinberg AD
Int Arch Allergy Appl Immunol; 1981; 66(3):293-303. PubMed ID: 7028641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
